V1 sact_drug_detail
6,385,827 rows · 11 columns
| MERGED_DRUG_DETAIL_ID | MERGED_CYCLE_ID | ORG_CODE_OF_DRUG_PROVIDER | ACTUAL_DOSE_PER_ADMINISTRATION | OPCS_DELIVERY_CODE | ADMINISTRATION_ROUTE | ADMINISTRATION_DATE | DRUG_GROUP | MERGED_PATIENT_ID | MERGED_TUMOUR_ID | MERGED_REGIMEN_ID |
|---|---|---|---|---|---|---|---|---|---|---|
| 16625707 | 330006201 | EKA | 0.75 | X721 | 1 | 2014-06-02 | CISPLATIN | 330000242 | 330002981 | 330006201 |
| 16625708 | 330006201 | E1UZ0 | 150 | X724 | 1 | 2014-06-02 | VINCRISTINE | 330000242 | 330002981 | 330006201 |
| 16625709 | 330006201 | EEI00 | 290 | X724 | 1 | 2014-06-02 | ETOPOSIDE | 330000242 | 330002981 | 330006201 |
| 16625710 | 330006201 | EE813 | 22 | null | 1 | 2014-06-03 | GEMCITABINE | 330000242 | 330002981 | 330006201 |
| 16625711 | 330006201 | EEI00 | 0 | null | 1 | 2014-06-03 | NOT CHEMO | 330000242 | 330002981 | 330006201 |
| 16625712 | 330006203 | EC4 | 5600 | X724 | 1 | 2014-12-12 | IFOSFAMIDE | 330000258 | 330011544 | 330006203 |
| 16625713 | 330006203 | ECL02 | 20 | X729 | 1 | 2014-12-13 | IFOSFAMIDE | 330000258 | 330011544 | 330006203 |
| 16625714 | 330006203 | EE813 | 8 | X721 | 2 | 2014-12-14 | MULTIPLE | 330000258 | 330011544 | 330006203 |
| 16625715 | 330006205 | ETG | 0 | x724 | 1 | 2016-11-21 | NUC-3373 | 330000263 | 330002991 | 330006205 |
| 16625716 | 330006205 | EE813 | 1000 | null | 1 | 2016-11-21 | DOXORUBICIN | 330000263 | 330002991 | 330006205 |
| 16625717 | 330006205 | EPH | 50 | X721 | 1 | 2016-11-22 | DOXORUBICIN | 330000263 | 330002991 | 330006205 |
| 16625718 | 330006205 | E1UZ0 | 50 | x724 | 2 | 2016-11-22 | ETOPOSIDE | 330000263 | 330002991 | 330006205 |
| 16625719 | 330006205 | EE813 | 2200 | X724 | 2 | 2016-11-22 | AVELUMAB | 330000263 | 330002991 | 330006205 |
| 16625720 | 330006205 | ECL02 | 585 | X724 | 1 | 2016-11-22 | DACTINOMYCIN | 330000263 | 330002991 | 330006205 |
| 16625721 | 330006205 | EE813 | 0 | N/A | 1 | 2016-11-22 | IFOSFAMIDE | 330000263 | 330002991 | 330006205 |
| 16625722 | 330006205 | ENW | 1300 | X721 | 1 | 2016-11-22 | FLUOROURACIL | 330000263 | 330002991 | 330006205 |
| 16625723 | 330006205 | ERA20 | 625 | X721 | 2 | 2016-11-22 | NOT CHEMO | 330000263 | 330002991 | 330006205 |
| 16625724 | 330006205 | EGENG | 1800 | X724 | 1 | 2016-11-22 | FLUOROURACIL | 330000263 | 330002991 | 330006205 |
| 16625725 | 330006205 | EX950 | 125 | X721 | 1 | 2016-11-23 | NOT CHEMO | 330000263 | 330002991 | 330006205 |
| 16625726 | 330006205 | EEX02 | 40 | null | 1 | 2016-11-24 | DOXORUBICIN | 330000263 | 330002991 | 330006205 |
| 16625727 | 330006205 | Haqrsvarq | 20 | X721 | 1 | 2016-11-24 | STEROID | 330000263 | 330002991 | 330006205 |
| 16625728 | 330006205 | EN710 | 2 | X723 | 1 | 2016-11-24 | MIFAMURTIDE | 330000263 | 330002991 | 330006205 |
| 16625729 | 330006206 | EOI | 0 | null | 1 | 2016-03-23 | NOT CHEMO | 330000276 | 330010140 | 330006206 |
| 16625730 | 330006206 | EON | 232 | X721 | 1 | 2016-03-23 | DOXORUBICIN | 330000276 | 330010140 | 330006206 |
| 16625731 | 330006206 | EUZ01 | 20 | null | 1 | 2016-03-23 | ETOPOSIDE | 330000276 | 330010140 | 330006206 |
| 16625732 | 330006206 | E1UZ0 | 5.6 | X292 | 1 | 2016-03-23 | GEMCITABINE | 330000276 | 330010140 | 330006206 |
| 16625733 | 330006206 | EOI | 1.05 | null | 1 | 2016-03-23 | CETUXIMAB | 330000276 | 330010140 | 330006206 |
| 16625734 | 330006206 | EGQ01 | 8 | X724 | 1 | 2016-03-23 | NOT CHEMO | 330000276 | 330010140 | 330006206 |
| 16625735 | 330006206 | EGQ01 | 230 | N/A | 1 | 2016-03-23 | IFOSFAMIDE | 330000276 | 330010140 | 330006206 |
| 16625736 | 330006206 | EJS03 | 6400 | X724 | 1 | 2016-03-24 | FLUOROURACIL | 330000276 | 330010140 | 330006206 |
| 16625737 | 330006206 | EN201 | 8 | X721 | 2 | 2016-03-24 | STEROID | 330000276 | 330010140 | 330006206 |
| 16625738 | 330006206 | ELW | 8 | X724 | 2 | 2016-03-24 | STEROID | 330000276 | 330010140 | 330006206 |
| 16625739 | 330006207 | ETG | 0 | null | 1 | 2015-04-23 | IFOSFAMIDE | 330000277 | 330002996 | 330006207 |
| 16625740 | 330006208 | EOI | 2 | X721 | 1 | 2016-04-19 | DOXORUBICIN | 330000287 | 330002997 | 330006208 |
| 16625741 | 330006208 | ETG | 8 | X721 | 1 | 2016-05-10 | DAUNORUBICIN | 330000287 | 330002997 | 330006208 |
| 16625742 | 330006209 | EC4 | 35 | N/A | 1 | 2015-08-29 | TRIAL | 330000287 | 330002998 | 330006209 |
| 16625743 | 330006209 | EEI00 | null | X292 | 1 | 2015-08-29 | NOT CHEMO | 330000287 | 330002998 | 330006209 |
| 16625744 | 330006209 | EPH | 485 | X721 | null | 2015-09-12 | TOPOTECAN | 330000287 | 330002998 | 330006209 |
| 16625745 | 330006209 | EK1EN | 1.5 | X722 | 1 | 2015-09-13 | TRIAL | 330000287 | 330002998 | 330006209 |
| 16625746 | 330006209 | ECL01 | 178 | X721 | 1 | 2015-09-13 | DACTINOMYCIN | 330000287 | 330002998 | 330006209 |
| 16625747 | 330006216 | EEI00 | 100 | X724 | 1 | 2014-05-23 | RITUXIMAB | 330000334 | 330003006 | 330006216 |
| 16625748 | 330006225 | ECL02 | 181 | null | 1 | 2017-05-13 | DOXORUBICIN | 330000392 | 330007611 | 330006225 |
| 16625749 | 330006225 | ELW | 210 | X729 | 1 | 2017-05-13 | IFOSFAMIDE | 330000392 | 330007611 | 330006225 |
| 16625750 | 330006225 | EOF | 50 | X721 | 1 | 2017-05-13 | BMS-986016 | 330000392 | 330007611 | 330006225 |
| 16625751 | 330006226 | EXO | 425 | null | 1 | 2016-04-30 | FLUOROURACIL | 330000393 | 330003020 | 330006226 |
| 16625752 | 330006226 | EPH | 1800 | null | 1 | 2016-05-01 | CYTARABINE | 330000393 | 330003020 | 330006226 |
| 16625753 | 330006226 | EEI00 | 0 | X721 | 1 | 2016-05-01 | CETUXIMAB | 330000393 | 330003020 | 330006226 |
| 16625754 | 330006227 | EOI | 437.5 | N/A | 1 | 2015-11-15 | NIVOLUMAB | 330000394 | 330007613 | 330006227 |
| 16625755 | 330006227 | EKA | 170 | X721 | 1 | 2015-11-15 | IRINOTECAN | 330000394 | 330007613 | 330006227 |
| 16625756 | 330006227 | EK1EN | 6000 | X724 | 1 | 2015-11-16 | NIVOLUMAB | 330000394 | 330007613 | 330006227 |